Form 8-K AtriCure, Inc. For: Apr 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
AtriCure Inc. (ATRC) PT Raised to $81 at Needham & Company
April 28, 2021 6:20 AM EDTNeedham & Company analyst Mike Matson raised the price target on AtriCure Inc. (NASDAQ: ATRC) to $81.00 (from $74.00) while maintaining a Buy rating.
The analyst commented, "ATRC's 1Q21 revenue, adjusted EBITDA, and adjusted EPS all beat consensus. The impact from the pandemic eased during the... More
